In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: A multicentre international trial

R. N. Jones, R. S. Hareb, F. J. Sabatelli, K. Aldridge, P. Della-Latta, M. J. Ferraro, R. Goering, J. Hindkler, D. Bruckner, M. Jacobs, D. Low, A. Medeiros, J. Boyce, B. Murray, F. Baquero, D. Costa, N. Frimodt-Møller, H. Goossens, D. Graninger, S. GudmundssonD. Gur, P. Huovinen, M. Kettner, E. Keuleyen, K. Klugman, R. Le Clercq, J. Patzer, G. Petrikkos, E. Lingaas, C. Nord, G. Reshedko, L. Stratchounski, J. Schindler, G. C. Schito, M. E. Jones, B. Wiedemann, R. Wise

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: A multicentre international trial'. Together they form a unique fingerprint.

Medicine & Life Sciences